BDX.AX · BCAL DIAGNOSTICS LIMITED
Australia · RS rating 65 · As of 2026-10-14
| Price | 0.08 AUD |
|---|---|
| 1-day change | -11.1% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 92 / 64 / 64 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 19 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +40.7% |
| Market cap (USD) | $23.1M |